31st Jan 2005 16:59
GlaxoSmithKline PLC31 January 2005 Director's Interests I give below details of changes in directors' interests in the Ordinary Sharesof GlaxoSmithKline plc. 27 January 2005 The Administrators of the SmithKline Beecham Employee Benefit Trust notified the Company on 31 January 2005 that 1806 Ordinary shares in the Company had been sold on 27 January 2005 on behalf of a participant in the SmithKline Beecham Bonus Investment Plan at a price of £11.71. The Trust also notified the Company on 31 January 2005 that 2,588 Ordinary shares had been transferred from the Trust to a participant in the SmithKline Beecham Bonus Investment Plan. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, John Coombe is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. S M BicknellCompany Secretary 31 January 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline